Page last updated: 2024-09-05

sorafenib and Rhabdomyosarcoma 2

sorafenib has been researched along with Rhabdomyosarcoma 2 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Pappo, A; Paulino, AC	1
Abraham, J; Carew, JS; Chua, YX; Druker, BJ; Giles, FJ; Glover, JM; Keller, C; Kilcoyne, A; Loriaux, MM; Michalek, JE; Nelon, LD; Ouyang, Y; Pal, R; Rubin, BP; Tyner, JW	1

Other Studies

2 other study(ies) available for sorafenib and Rhabdomyosarcoma 2

Article	Year
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk? Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine	2009
An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma. Biochemical and biophysical research communications, 2012, Sep-28, Volume: 426, Issue:3 Topics: Animals; Benzamides; Benzenesulfonates; Cell Proliferation; Drug Resistance, Neoplasm; Imatinib Mesylate; Mice; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; raf Kinases; Receptor, Platelet-Derived Growth Factor alpha; Rhabdomyosarcoma, Alveolar; Sorafenib; src-Family Kinases; Tumor Cells, Cultured	2012

Article

Year

Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?

Pediatric blood & cancer, 2009, Dec-15, Volume: 53, Issue:7

Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine

2009

An adaptive Src-PDGFRA-Raf axis in rhabdomyosarcoma.

Biochemical and biophysical research communications, 2012, Sep-28, Volume: 426, Issue:3

Topics: Animals; Benzamides; Benzenesulfonates; Cell Proliferation; Drug Resistance, Neoplasm; Imatinib Mesylate; Mice; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; raf Kinases; Receptor, Platelet-Derived Growth Factor alpha; Rhabdomyosarcoma, Alveolar; Sorafenib; src-Family Kinases; Tumor Cells, Cultured

2012